These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20924409)

  • 21. Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations.
    Bishop JA; Wachsmuth RC; Harland M; Bataille V; Pinney E; MacK P; Baglietto L; Cuzick J; Bishop DT
    J Invest Dermatol; 2000 Jan; 114(1):28-33. PubMed ID: 10620111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Problems in the definition, interpretation, and evaluation of genetic heterogeneity.
    Whittemore AS; Halpern J
    Am J Hum Genet; 2001 Feb; 68(2):457-65. PubMed ID: 11170893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
    Antoniou AC; Durocher F; Smith P; Simard J; Easton DF;
    Breast Cancer Res; 2006; 8(1):R3. PubMed ID: 16417652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers.
    Kramer JL; Velazquez IA; Chen BE; Rosenberg PS; Struewing JP; Greene MH
    J Clin Oncol; 2005 Dec; 23(34):8629-35. PubMed ID: 16314625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Designing studies to estimate the penetrance of an identified autosomal dominant mutation: cohort, case-control, and genotyped-proband designs.
    Gail MH; Pee D; Benichou J; Carroll R
    Genet Epidemiol; 1999; 16(1):15-39. PubMed ID: 9915565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Likelihood formulation of parent-of-origin effects on segregation analysis, including ascertainment.
    Haghighi F; Hodge SE
    Am J Hum Genet; 2002 Jan; 70(1):142-56. PubMed ID: 11741195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bias and efficiency in family-based gene-characterization studies: conditional, prospective, retrospective, and joint likelihoods.
    Kraft P; Thomas DC
    Am J Hum Genet; 2000 Mar; 66(3):1119-31. PubMed ID: 10712222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancer.
    Heimdal K; Maehle L; Apold J; Pedersen JC; Møller P
    Eur J Cancer; 2003 Oct; 39(15):2205-13. PubMed ID: 14522380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age.
    van der Kolk DM; de Bock GH; Leegte BK; Schaapveld M; Mourits MJ; de Vries J; van der Hout AH; Oosterwijk JC
    Breast Cancer Res Treat; 2010 Dec; 124(3):643-51. PubMed ID: 20204502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel approach to detect parent-of-origin effects from pedigree data with application to Beckwith-Wiedemann syndrome.
    Shete S; Elston RC; Lu Y
    Ann Hum Genet; 2007 Nov; 71(Pt 6):804-14. PubMed ID: 17578507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complexity and power in case-control association studies.
    Longmate JA
    Am J Hum Genet; 2001 May; 68(5):1229-37. PubMed ID: 11294658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotype-phenotype correlations in hereditary familial retinoblastoma.
    Taylor M; Dehainault C; Desjardins L; Doz F; Levy C; Sastre X; Couturier J; Stoppa-Lyonnet D; Houdayer C; Gauthier-Villars M
    Hum Mutat; 2007 Mar; 28(3):284-93. PubMed ID: 17096365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Penetrance of inherited medullary thyroid carcinoma and genotype-phenotype correlation in a large multiple endocrine neoplasia type 2A family with C634Y RET mutation.
    González-Yebra B; Medrano ME; Mantilla A; Palma V; Colin C; Hernández DM; Tapia J; Dawson B; Salcedo M
    Endocr Pathol; 2003; 14(1):71-80. PubMed ID: 12746565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association and aggregation analysis using kin-cohort designs with applications to genotype and family history data from the Washington Ashkenazi Study.
    Chatterjee N; Shih J; Hartge P; Brody L; Tucker M; Wacholder S
    Genet Epidemiol; 2001 Sep; 21(2):123-38. PubMed ID: 11507721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Penetrance of LGI1 mutations in autosomal dominant partial epilepsy with auditory features.
    Rosanoff MJ; Ottman R
    Neurology; 2008 Aug; 71(8):567-71. PubMed ID: 18711109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.
    Tryggvadottir L; Sigvaldason H; Olafsdottir GH; Jonasson JG; Jonsson T; Tulinius H; Eyfjörd JE
    J Natl Cancer Inst; 2006 Jan; 98(2):116-22. PubMed ID: 16418514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A method for estimating cancer risk in p53 mutation carriers.
    Le Bihan C; Bonaiti-Pellie C
    Cancer Detect Prev; 1994; 18(3):171-8. PubMed ID: 8076379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Parent-of-Origin Effect Impacts the Phenotype in Low Penetrance Retinoblastoma Families Segregating the c.1981C>T/p.Arg661Trp Mutation of RB1.
    Eloy P; Dehainault C; Sefta M; Aerts I; Doz F; Cassoux N; Lumbroso le Rouic L; Stoppa-Lyonnet D; Radvanyi F; Millot GA; Gauthier-Villars M; Houdayer C
    PLoS Genet; 2016 Feb; 12(2):e1005888. PubMed ID: 26925970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiplex melanoma families are enriched for polygenic risk.
    Law MH; Aoude LG; Duffy DL; Long GV; Johansson PA; Pritchard AL; Khosrotehrani K; Mann GJ; Montgomery GW; Iles MM; Cust AE; Palmer JM; ; Shannon KF; Spillane AJ; Stretch JR; Thompson JF; Saw RPM; Scolyer RA; Martin NG; Hayward NK; MacGregor S
    Hum Mol Genet; 2020 Oct; 29(17):2976-2985. PubMed ID: 32716505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dominant negative ATM mutations in breast cancer families.
    Chenevix-Trench G; Spurdle AB; Gatei M; Kelly H; Marsh A; Chen X; Donn K; Cummings M; Nyholt D; Jenkins MA; Scott C; Pupo GM; Dörk T; Bendix R; Kirk J; Tucker K; McCredie MR; Hopper JL; Sambrook J; Mann GJ; Khanna KK
    J Natl Cancer Inst; 2002 Feb; 94(3):205-15. PubMed ID: 11830610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.